Published in N Engl J Med on May 21, 1981
Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest (1990) 1.27
Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors. Endocrinology (2011) 1.14
Glycoprotein hormone genes are expressed in clinically nonfunctioning pituitary adenomas. J Clin Invest (1987) 0.91
Glycoprotein hormone alpha-subunit-producing pituitary adenomas in rats treated for one year with calcitonin. Am J Pathol (1992) 0.75
Fluorescence histochemistry of RNA in human pituitary adenomas. Acta Neuropathol (1989) 0.75
The Colorado thyroid disease prevalence study. Arch Intern Med (2000) 7.84
The Millennium Project: a plan for meeting the Millennium Development Goals. Lancet (2005) 7.70
Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA (1995) 3.68
Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology (2000) 3.67
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science (1974) 3.20
Guidelines for acromegaly management: an update. J Clin Endocrinol Metab (2009) 2.96
Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med (2000) 2.80
Eating disorders. N Engl J Med (1999) 2.77
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2008) 2.70
A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab (2010) 2.33
Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab (1996) 2.30
Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA (1996) 2.30
Determinants of increased energy expenditure in HIV-infected women. Am J Clin Nutr (1998) 2.21
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med (2000) 2.16
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet (2001) 2.08
Failure of perchlorate to inhibit Tc-99m isonitrile binding by the thyroid during myocardial perfusion studies. Clin Nucl Med (1991) 2.05
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab (2005) 1.98
Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab (2001) 1.95
NIH conference. Insulin-like growth factors in health and disease. Ann Intern Med (1992) 1.95
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
Changes in regional fat redistribution and the effects of estrogen during spontaneous weight gain in women with anorexia nervosa. Am J Clin Nutr (2001) 1.91
Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab (1998) 1.91
The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab (1999) 1.89
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab (1998) 1.89
L-Thyroxine therapy in subclinical hypothyroidism. A double-blind, placebo-controlled trial. Ann Intern Med (1984) 1.88
A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty. J Clin Endocrinol Metab (1996) 1.85
Delayed menarche and amenorrhea of college athletes in relation to age of onset of training. JAMA (1981) 1.84
Thyroid hormone regulates the mouse thyrotropin beta-subunit gene promoter in transfected primary thyrotropes. J Biol Chem (1989) 1.84
Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med (1997) 1.75
Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med (2000) 1.74
Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab (2000) 1.73
Subclinical hypothyroidism is mild thyroid failure and should be treated. J Clin Endocrinol Metab (2001) 1.72
The influence of gonadal hormones on conditioned fear extinction in healthy humans. Neuroscience (2010) 1.69
Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab (1998) 1.68
Lymphocytic (microscopic) colitis. Clinicopathologic study of 18 patients and comparison to collagenous colitis. Dig Dis Sci (1989) 1.65
Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab (1998) 1.65
Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab (1989) 1.61
Phenotypic delineation of ring chromosome 15 and Russell-Silver syndromes. J Med Genet (1985) 1.59
Osteopenia in men with a history of delayed puberty. N Engl J Med (1992) 1.59
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med (1996) 1.57
Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metab (1998) 1.57
Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. N Engl J Med (1977) 1.55
Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab (1996) 1.54
Thyroid hormone resistance syndromes. Am J Med (1993) 1.54
Decreased bone density in hyperprolactinemic women. N Engl J Med (1980) 1.53
Assessment of macronutrient and micronutrient intake in women with anorexia nervosa. Int J Eat Disord (2000) 1.49
Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science (1981) 1.48
Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol (1984) 1.47
Induction of menstrual disorders by strenuous exercise in untrained women. N Engl J Med (1985) 1.47
Body fat distribution measured with CT: correlations in healthy subjects, patients with anorexia nervosa, and patients with Cushing syndrome. Radiology (1989) 1.46
Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs. Stroke (1990) 1.44
Hypothyroidism-induced macroorchidism: use of a gonadotropin-releasing hormone agonist to understand its mechanism and augment adult stature. J Clin Endocrinol Metab (1995) 1.43
Physical conditioning facilitates the exercise-induced secretion of beta-endorphin and beta-lipotropin in women. N Engl J Med (1981) 1.41
Secondary malignancy of the thyroid gland: a case report and review of the literature. Thyroid (1994) 1.41
Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann Neurol (1983) 1.36
Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab (1997) 1.36
Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. N Engl J Med (1994) 1.36
Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med (1987) 1.34
Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med (1996) 1.34
Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea. J Clin Endocrinol Metab (1992) 1.34
Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med (1986) 1.34
Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med (2000) 1.33
Transcriptional regulation of the thyrotropin subunit genes by thyroid hormone. J Biol Chem (1985) 1.33
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid (1998) 1.33
Endocrine disorders in men infected with human immunodeficiency virus. Am J Med (1988) 1.32
Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab (2004) 1.31
Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea. J Clin Endocrinol Metab (1999) 1.31
Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial. JAMA (1998) 1.30
Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug dose. Ann Intern Med (1983) 1.29
Consequence of ligation of the vertebral artery. J Neurosurg (1972) 1.27
Biologically active luteinizing hormone is secreted in episodic pulsations that vary in relation to stage of the menstrual cycle. J Clin Endocrinol Metab (1984) 1.27
Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab (2006) 1.27
Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. J Clin Invest (1973) 1.27
Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function. Mol Endocrinol (2006) 1.27
Idiopathic spinal cord herniation: a treatable cause of the Brown-Sequard syndrome--case report. Neurosurgery (1995) 1.27
Clinically nonfunctioning pituitary tumors are monoclonal in origin. J Clin Invest (1990) 1.27
A consensus on the diagnosis and treatment of acromegaly complications. Pituitary (2013) 1.26
Effects of fasting and glucose infusion on basal and overnight leptin concentrations in normal-weight women. Am J Clin Nutr (1997) 1.26
Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab (1996) 1.26
Adrenoleukodystrophy. Endocrinol Metab Clin North Am (1991) 1.26
The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab (2012) 1.25
Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab (1978) 1.24
Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med (1987) 1.23
Sucralfate causes malabsorption of L-thyroxine. Am J Med (1994) 1.22
The effect of pregnancy upon endometriosis. Obstet Gynecol Surv (1965) 1.22
Simulation of the normal menstrual cycle in Kallman's syndrome by pulsatile administration of luteinizing hormone-releasing hormone (LHRH). J Clin Endocrinol Metab (1980) 1.22